UB Paderborn / Katalog / Suche / in CDI

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

1 – 25 von 2.183

Sortiert nach

Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

Arthritis & rheumatology (Hoboken, N.J.), 2017-10, Vol.69 (10), p.1960-1968

2017

Volltextzugriff (PDF)

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

The Lancet (British edition), 2013-08, Vol.382 (9894), p.780-789

2013

Volltextzugriff (PDF)

The Protective Effects of Estrogen on the Cardiovascular System

The New England journal of medicine, 1999-06, Vol.340 (23), p.1801-1811

1999

Volltextzugriff (PDF)

Cost-effectiveness analysis of two-way texting for post-operative follow-up in Zimbabwe's voluntary medical male circumcision program

PloS one, 2020-09, Vol.15 (9), p.e0239915-e0239915

2020

Volltextzugriff (PDF)

Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis

The Journal of dermatological treatment, 2022-05, Vol.33 (3), p.1670-1675

2022

Volltextzugriff (PDF)

Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials

The Journal of dermatological treatment, 2022-01, Vol.33 (1), p.219-228

2022

Volltextzugriff (PDF)

Estrogen Receptor α and Endothelial Nitric Oxide Synthase Are Organized Into a Functional Signaling Module in Caveolae

Circulation research, 2000-11, Vol.87 (11), p.e44-e52

2000

Volltextzugriff (PDF)

Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States

The Journal of dermatological treatment, 2022-02, Vol.33 (2), p.740-748

2022

Volltextzugriff (PDF)

Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status

The Journal of dermatological treatment, 2021-02, Vol.32 (2), p.203-211

2021

Volltextzugriff (PDF)

Visualizing Sexual Dimorphism in the Brain

Neuron (Cambridge, Mass.), 2004-08, Vol.43 (3), p.313-319

2004

Volltextzugriff (PDF)

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

Annals of the rheumatic diseases, 2014-06, Vol.73 (6), p.990-999

2014

Volltextzugriff (PDF)

Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasis

The Journal of dermatological treatment, 2020-11, Vol.31 (8), p.763-768

2020

Volltextzugriff (PDF)

Efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 64‐week phase 3 study (reSURFACE 1)

Journal of dermatology, 2021-06, Vol.48 (6), p.853-863

2021

Volltextzugriff (PDF)

Estrogen actions in the cardiovascular system

Climacteric : the journal of the International Menopause Society, 2009-01, Vol.12 (s1), p.18-21

Mendelsohn, M. E.

2009

Volltextzugriff (PDF)

Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL Study

Dermatology and therapy, 2023-06, Vol.13 (6), p.1255-1264

2023

Volltextzugriff (PDF)

Odorant Receptors on Axon Termini in the Brain

Science (American Association for the Advancement of Science), 2004-06, Vol.304 (5676), p.1468-1468

2004

Volltextzugriff (PDF)

Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials

Annals of the rheumatic diseases, 2014-06, Vol.73 (6), p.1000-1006

2014

Volltextzugriff (PDF)

Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)

British journal of dermatology (1951), 2021-08, Vol.185 (2), p.323-334

2021

Volltextzugriff (PDF)

Community Connectedness, Challenges, and Resilience Among Gay Latino Immigrants

American journal of community psychology, 2015-03, Vol.55 (1-2), p.202-214

2015

Volltextzugriff (PDF)

Outcomes of pregnancies from the tildrakizumab phase I–III clinical development programme

British journal of dermatology (1951), 2020-07, Vol.183 (1), p.184-186

2020

Volltextzugriff (PDF)

Estrogen Inhibits the Vascular Injury Response in Estrogen Receptor β -Deficient Female Mice

Proceedings of the National Academy of Sciences - PNAS, 1999-12, Vol.96 (26), p.15133-15136

1999

Volltextzugriff (PDF)

Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: Evidence for chamber-specific molecular determinants of conduction

Circulation (New York, N.Y.), 1998-02, Vol.97 (7), p.686-691

1998

Volltextzugriff (PDF)

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

Nature medicine, 2001-07, Vol.7 (7), p.853-857

2001

Volltextzugriff (PDF)

Human vascular smooth muscle cells contain functional estrogen receptor

Circulation (New York, N.Y.), 1994-05, Vol.89 (5), p.1943-1950

1994

Volltextzugriff (PDF)

Increased Expression of Estrogen Receptor-beta mRNA in Male Blood Vessels After Vascular Injury

Circulation research, 1998-07, Vol.83 (2), p.224-229

1998

Volltextzugriff (PDF)

1 – 25 von 2.183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.632)
Mit Volltextzugriff
(1.616)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

n.n

Thema

Science & Technology
(1.100)
Life Sciences & Biomedicine
(988)
Humans
(829)
Female
(443)
Male
(439)
Biological And Medical Sciences
(429)
Animals
(358)
Medical Sciences
(277)
Adult
(210)
Middle Aged
(180)
Fundamental And Applied Biological Sciences. Psychology
(171)
Mice
(152)
Aged
(137)
Cardiovascular System & Cardiology
(113)
Oncology
(112)
Child
(108)
Biochemistry & Molecular Biology
(101)
Pediatrics
(95)
Social Sciences
(95)
Cardiac & Cardiovascular Systems
(93)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.107)
EZB Electronic Journals Library
(768)
Journals@Ovid Complete
(726)
IngentaConnect
(718)
Publisher website
(617)
Elsevier ScienceDirect Journals Complete
(431)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(285)
IngentaConnect Journals
(267)
Wiley Online Library Journals Frontfile Complete
(248)
Wiley Online Library Full Collection 2018
(190)
Jstor Complete Legacy
(168)
Ebook Central Perpetual and DDA
(130)
Oxford Journals
(111)
Nexis Uni
(92)
ScienceDirect eBooks
(89)
SpringerLink
(83)
Oxford Journals 2020 Medicine
(76)
Taylor & Francis
(69)
PAIS Index
(66)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(60)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)